Novartis AG (SWX: NOVN)
Switzerland
· Delayed Price · Currency is CHF 100.92
-0.44 (-0.43%)
Sep 4, 2024, 5:30 PM CET
Novartis AG Employees
Novartis AG had 76,057 employees as of December 31, 2023. The number of employees decreased by 25,646 or -25.22% compared to the previous year.
Employees
76,057
Change (1Y)
-25,646
Growth (1Y)
-25.22%
Revenue / Employee
577.27K CHF
Profits / Employee
191.10K CHF
Market Cap
205.21B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 76,057 | -25,646 | -25.22% |
| Dec 31, 2022 | 101,703 | -2,620 | -2.51% |
| Dec 31, 2021 | 104,323 | -1,471 | -1.39% |
| Dec 31, 2020 | 105,794 | 1,880 | 1.81% |
| Dec 31, 2019 | 103,914 | -21,247 | -16.98% |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
| Dec 31, 2014 | Pro | Pro | Pro |
Novartis AG News
- 6 hours ago - Novartis expands U.S. radiopharma production amid rising competition - Seeking Alpha
- 6 days ago - Competitor Analysis: Evaluating Johnson & Johnson And Competitors In Pharmaceuticals Industry - Benzinga
- 6 days ago - Natco Pharma submits ANDA for generic version of Tabrecta, a $126M US market drug - Business Upturn
- 7 days ago - Comparing Merck & Co With Industry Competitors In Pharmaceuticals Industry - Benzinga
- 7 days ago - Novartis' Cholesterol-Lowering Drug Shows Encouraging Outcome In Late-Stage Study - Benzinga
- 7 days ago - Lindy Biosciences Enters Licensing and Collaboration Agreement With Novartis for Multi-target Drug Delivery Innovation - Business Wire
- 7 days ago - Novartis twice-yearly* Leqvio® demonstrated clinically meaningful, statistically significant LDL-C lowering as a monotherapy in patients at low or moderate ASCVD risk - GlobeNewsWire
- 9 days ago - Galapagos Surges On An FDA Win For Its Rival To Gilead, Novartis; But There Are Some Caveats - Investor's Business Daily